JP2015504870A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015504870A5 JP2015504870A5 JP2014547526A JP2014547526A JP2015504870A5 JP 2015504870 A5 JP2015504870 A5 JP 2015504870A5 JP 2014547526 A JP2014547526 A JP 2014547526A JP 2014547526 A JP2014547526 A JP 2014547526A JP 2015504870 A5 JP2015504870 A5 JP 2015504870A5
- Authority
- JP
- Japan
- Prior art keywords
- angiotensin
- disorder
- derivative
- analog
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- PVHLMTREZMEJCG-GDTLVBQBSA-N Ile(5)-angiotensin II (1-7) Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 PVHLMTREZMEJCG-GDTLVBQBSA-N 0.000 claims 1
- 108010021281 angiotensin I (1-7) Proteins 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 230000003176 fibrotic effect Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161576673P | 2011-12-16 | 2011-12-16 | |
| US61/576,673 | 2011-12-16 | ||
| US201161579936P | 2011-12-23 | 2011-12-23 | |
| US61/579,936 | 2011-12-23 | ||
| PCT/US2012/069930 WO2013090833A1 (en) | 2011-12-16 | 2012-12-14 | Angiotensins for treatment of fibrosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015504870A JP2015504870A (ja) | 2015-02-16 |
| JP2015504870A5 true JP2015504870A5 (enExample) | 2016-02-12 |
Family
ID=48613248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014547526A Pending JP2015504870A (ja) | 2011-12-16 | 2012-12-14 | 線維症を処置するためのアンジオテンシン |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20150057216A1 (enExample) |
| EP (1) | EP2790716A4 (enExample) |
| JP (1) | JP2015504870A (enExample) |
| KR (1) | KR20150028761A (enExample) |
| CN (1) | CN104302305A (enExample) |
| AU (1) | AU2012351939A1 (enExample) |
| BR (1) | BR112014014674A2 (enExample) |
| CA (1) | CA2859573A1 (enExample) |
| WO (1) | WO2013090833A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2635581C (en) | 2005-12-28 | 2017-02-28 | Vertex Pharmaceuticals Incorporated | Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| CN105451756A (zh) * | 2013-05-24 | 2016-03-30 | 塔瑞克斯制药有限公司 | 在治疗马凡氏综合征及其相关病症中的血管紧张素肽 |
| WO2015002903A1 (en) | 2013-07-03 | 2015-01-08 | Arizona Board Of Regents For The University Of Arizona | Method for treating cognitive dysfunction |
| US20170080120A1 (en) * | 2014-05-16 | 2017-03-23 | Ulstrast, Inc. | Phase-shifting formulations |
| AU2015294371B2 (en) | 2014-07-21 | 2018-02-01 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Ang-(1-7) derivative oligopeptides and methods for using and producing the same |
| US10183055B2 (en) | 2014-07-21 | 2019-01-22 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications |
| RU2749213C2 (ru) | 2014-10-07 | 2021-06-07 | Вертекс Фармасьютикалз Инкорпорейтед | Сокристаллы модуляторов регулятора трансмембранной проводимости при кистозном фиброзе |
| MA41120A (fr) * | 2014-12-02 | 2017-10-10 | Afimmune Ltd | Compositions comprenant le 15-hepe et méthodes de traitement ou de prévention de la fibrose à l'aide de celles-ci |
| US10100311B2 (en) * | 2015-07-30 | 2018-10-16 | Monash University | Fibrotic treatment |
| EP3373951B1 (en) | 2015-10-14 | 2021-11-17 | Tarix Pharmaceuticals Ltd. | Methods and compositions for the treatment of epidermolysis bullosa |
| WO2017218623A1 (en) * | 2016-06-14 | 2017-12-21 | Tarix Orphan Llc | Methods and compositions for the treatment of epidermolysis bullosa |
| WO2019014710A1 (en) * | 2017-07-17 | 2019-01-24 | Monash University | ANGIOTENSIN RECEPTOR AGONISTS AND USES THEREOF |
| GB201913603D0 (en) * | 2019-09-20 | 2019-11-06 | Vicore Pharma Ab | New compounds |
| WO2021164723A1 (en) * | 2020-02-20 | 2021-08-26 | Lee Sheau Long | Ginsenoside m1 as a modulator of angiotensin regulating enzymes and its use for treating diseases or conditions including symptoms caused by coronavirus |
| US20210315851A1 (en) | 2020-04-03 | 2021-10-14 | Afimmune Limited | Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases |
| EP4085921A1 (en) * | 2021-05-04 | 2022-11-09 | CU-Pharmaceuticals UG | Angiotensin-(1-7) in the treatment of sars-cov related diseases |
| WO2023152503A1 (en) | 2022-02-10 | 2023-08-17 | Vicore Pharma Ab | Use of buloxibutid for the treatment of idiopathic pulmonary fibrosis |
| GB202201723D0 (en) | 2022-02-10 | 2022-03-30 | Vicore Pharma Ab | New use |
| WO2025050228A1 (es) * | 2023-09-08 | 2025-03-13 | Pontificia Universidad Católica De Chile | Composición farmacéutica que comprende un péptido o una combinación de péptidos agonistas de los receptores mas, at1 y at2 |
| KR102743940B1 (ko) | 2023-10-06 | 2024-12-19 | 엠브릭스 주식회사 | 안지오텐신 전환효소 2 및 Fc 절편을 포함하는 나노디스크 및 이의 용도 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1036089B1 (en) * | 1997-12-12 | 2004-06-09 | University Of Southern California | Wound healing compositions |
| YU78601A (sh) * | 1999-05-05 | 2005-07-19 | Aventis Pharma Deutschland Gmbh. | 1-(p-tienilbenzil)-imidazoli kao agonisti angiotenzin-(1-7)- receptora, postupak za njihovu proizvodnju, njihova primena i farmaceutski preparati koji ih sadrže |
| US7064127B2 (en) * | 2003-12-19 | 2006-06-20 | Mount Sinai School Of Medicine Of New York University | Treatment of hepatic fibrosis with imatinib mesylate |
| ES2393455T3 (es) * | 2008-09-12 | 2012-12-21 | Charité-Universitátsmedizin Berlin (Charité) | Uso de un agonista del receptor Ang-(1-7) en lesiones pulmonares agudas |
-
2012
- 2012-12-14 CA CA2859573A patent/CA2859573A1/en not_active Abandoned
- 2012-12-14 KR KR20147019878A patent/KR20150028761A/ko not_active Withdrawn
- 2012-12-14 JP JP2014547526A patent/JP2015504870A/ja active Pending
- 2012-12-14 BR BR112014014674A patent/BR112014014674A2/pt not_active Application Discontinuation
- 2012-12-14 WO PCT/US2012/069930 patent/WO2013090833A1/en not_active Ceased
- 2012-12-14 US US14/365,565 patent/US20150057216A1/en not_active Abandoned
- 2012-12-14 EP EP12857486.0A patent/EP2790716A4/en not_active Withdrawn
- 2012-12-14 CN CN201280069856.3A patent/CN104302305A/zh active Pending
- 2012-12-14 AU AU2012351939A patent/AU2012351939A1/en not_active Abandoned
-
2015
- 2015-11-23 US US14/948,985 patent/US20160074466A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015504870A5 (enExample) | ||
| JP2015503422A5 (enExample) | ||
| JP2014530840A5 (enExample) | ||
| JP2015528502A5 (enExample) | ||
| JP2012143233A5 (enExample) | ||
| JP2013525942A5 (enExample) | ||
| JP2014520248A5 (enExample) | ||
| BR112014004181A2 (pt) | composto, composição farmacêutica, e, método de tratamento, prevenção, e / ou retardo do início de uma doença ou patologia | |
| JP2011170856A5 (enExample) | ||
| HUE045629T2 (hu) | Készítmények, alkalmazások és eljárások anyagcsere rendellenességek és betegségek kezelésére | |
| LT3470063T (lt) | Farmacinės kompozicijos, skirtos cftr nulemtų ligų gydymui | |
| LT3251678T (lt) | Benzoksaborolo dariniai, skirti bakterinių infekcijų gydymui | |
| JP2013514381A5 (enExample) | ||
| JP2016515522A5 (enExample) | ||
| BRPI0917567A2 (pt) | tratamento de doença respiratória | |
| HUE054621T2 (hu) | Gyógyászáti készítmény, kezelési eljárások és alkalmazásaik | |
| EP2799540A4 (en) | HUMAN ARGINASE AND PEGYLATED HUMAN ARGINASE AND USE THEREOF | |
| LT3292875T (lt) | Kompozicijos ir būdai, skirti ligų gydymui | |
| JP2014526140A5 (enExample) | ||
| JP2015525757A5 (enExample) | ||
| ZA201402907B (en) | Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies | |
| BRPI0906606A2 (pt) | Tratamento terapêutico para condições do pulmão. | |
| LTPA2020511I1 (lt) | Ciklezonidas, skirtas arklių kvėpavimo takų ligų gydymui | |
| HUE041883T2 (hu) | Samidorphan (ALKS 33) és buprenorfin kombináció, depressziós zavarok kezelésére | |
| BR112014009789A2 (pt) | cisteamina no tratamento da doença fibrótica |